Stockscreener 앱 받기
2.39
0.83%
-0.02
시간 외 거래:
2.39
전일 마감가:
$2.41
열려 있는:
$2.37
하루 거래량:
594.06K
Relative Volume:
1.22
시가총액:
$70.76M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-0.5975
EPS:
-4
순현금흐름:
$-21.66M
1주 성능:
-9.13%
1개월 성능:
+1.27%
6개월 성능:
-29.29%
1년 성능:
-31.91%
1일 변동 폭
$2.3301
$2.45
1주일 범위
$2.3301
$2.765
52주 변동 폭
$1.58
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
명칭
Nrx Pharmaceuticals Inc
전화
484-254-6134
주소
1201 ORANGE STREET, WILMINGTON
NRXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.39 | 71.35M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | H.C. Wainwright | Buy |
| 2025-04-02 | 개시 | BTIG Research | Buy |
Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스
A High-Stakes Alliance Aims to Standardize Mental Health Care at Scale - MyChesCo
Will NRx Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 20252026 world cup usa national team semifinals star players set piece tactics odds analysis preview - Улправда
NRx Pharmaceuticals (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network - Digital Journal
NRx Pharmaceuticals and neurocare group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and Other Mental Health Afflictions - citybiz
D. Boral Capital Reaffirms "Buy" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
NRx Pharmaceuticals and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Investing News Network
NRx and neurocare partner to create nationwide neuroplastic care network - Investing.com
NRx and neurocare partner to create nationwide neuroplastic care network By Investing.com - Investing.com Australia
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - The Manila Times
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Breakout Zone: Is NRx Pharmaceuticals Inc Equity Warrant stock in correction or buying zone2025 Growth vs Value & Safe Entry Trade Signal Reports - moha.gov.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
NRx Pharmaceuticals Completes Debt Repayment, Ends 2025 Debt-Free - The Globe and Mail
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Short Interest Up 38.2% in December - MarketBeat
NRX Pharmaceuticals, Inc. Eliminates All Balance Sheet Debt - TradingView — Track All Markets
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Sentinel-Standard
NRx’s preservative-free ketamine reaches FDA review as company targets 2026 launch - MSN
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP) - Idaho Statesman
Earnings Update: Why hedge funds are buying NRx Pharmaceuticals Inc. stockPortfolio Update Summary & Risk Controlled Swing Trade Alerts - moha.gov.vn
NRX Pharmaceuticals Earnings Notes - Trefis
Bearish Setup: Will NRx Pharmaceuticals Inc. Equity Warrant stock outperform value stocksJuly 2025 Opening Moves & Daily Volume Surge Signals - moha.gov.vn
Is NRx Pharmaceuticals Inc. stock a top momentum play2025 Buyback Activity & Safe Capital Investment Plans - ulpravda.ru
Will NRx Pharmaceuticals Inc. stock pay special dividends2025 Retail Activity & Low Drawdown Momentum Ideas - Улправда
Can NRx Pharmaceuticals Inc. stock beat market expectations this quarterEarnings Summary Report & Growth Oriented Trading Recommendations - DonanımHaber
Published on: 2025-12-19 15:23:52 - DonanımHaber
Why NRx Pharmaceuticals Inc. Equity Warrant stock is a value investor pickWeekly Stock Summary & Risk Adjusted Buy/Sell Alerts - DonanımHaber
Can NRx Pharmaceuticals Inc. stock withstand economic slowdownWatch List & Technical Buy Zone Confirmations - DonanımHaber
Is NRx Pharmaceuticals Inc. stock a buy in volatile markets2025 Earnings Surprises & Real-Time Stock Price Movement Reports - Улправда
NRx Pharmaceuticals (NASDAQ: NRXP) Eliminates Balance Sheet Debt Through Anson Equity Conversion - Digital Journal
Why NRx Pharmaceuticals Inc. Equity Warrant stock could see breakout soonJuly 2025 Short Interest & Stepwise Trade Execution Plans - Улправда
What momentum indicators show for NRx Pharmaceuticals Inc. stockTrade Risk Summary & High Return Stock Watch Alerts - Улправда
NRx Pharmaceuticals clears remaining $5.4 million debt By Investing.com - Investing.com Nigeria
Can NRx Pharmaceuticals Inc. stock rebound after recent weakness2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - Улправда
NRx Pharmaceuticals Announces Elimination of All Balance Sheet Debt Following Equity Conversion - citybiz
NRx Pharmaceuticals announces elimination of all balance sheet debt following equity conversion - Investing News Network
NRx Pharmaceuticals clears remaining $5.4 million debt - Investing.com
NRx Pharmaceuticals Completes Repayment of $5.4 Million Debt, Positioning Company for Growth in 2026 - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion - marketscreener.com
NRx Pharmaceuticals (NASDAQ:NRXP) Given Buy Rating at HC Wainwright - MarketBeat
NRXP: HC Wainwright & Co. Reiterates Buy Rating with $40 Target - GuruFocus
HC Wainwright & Co. Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq
Market Outlook: Does NRx Pharmaceuticals Inc stock trade at a discount to peersJuly 2025 Drop Watch & Stock Timing and Entry Methods - moha.gov.vn
[S-3/A] NRX Pharmaceuticals, Inc. Amended Shelf Registration Statement | NRXP SEC FilingForm S-3/A - Stock Titan
NRx Eyes Faster Commercial Path as NRX-101 Moves Into TMS-Enhanced Depression Treatment - MyChesCo
NRx’s Preservative-Free Ketamine Reaches FDA Review as Company Targets 2026 Launch - MyChesCo
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Gross profit of NRX Pharmaceuticals, Inc. – HAM:B1Q - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP), Akebia Therapeutics (AKBA) and Ionis Pharmaceuticals (IONS) - The Globe and Mail
Cash from financing activities of NRX Pharmaceuticals, Inc. – HAM:B1Q - TradingView
Is NRx Pharmaceuticals Inc. stock a bargain at current levelsMarket Rally & Weekly Top Stock Performers List - Newser
BTIG Research Reiterates Buy Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
Nrx Pharmaceuticals Inc (NRXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):